TLR3 and neoplasm: Thus, it can be concluded that the siRNAs and their complexation with mPPI did not interfere with TLR3 signaling and that the moderate anti-tumor effects observed after systemic administration of polyplexes containing the control antibody in PC3PSCA tumor-bearing mice are based on the non-targeted delivery of siSurv.